Back
Regeneron Pharmaceuticals, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
56
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$731.92
Seasonality Move:
20.45%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiRegeneron Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 27.1% based on the past 34 years of stock performance.
-
Regeneron Pharmaceuticals, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
-
Is Regeneron Pharmaceuticals, Inc. Stock Undervalued?The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $722.80. The Score for REGN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 27.1% based on the past 34 years of stock performance.
Regeneron Pharmaceuticals, Inc. Stock Rating
Buy
56
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. overpriced?
-
Regeneron Pharmaceuticals, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
Regeneron Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
800.99
52-Week Low:
476.49
Prediction Charts
Market Cap:
76B
Price in USD:
722.80
Volume:
1.1M
Beta:
0.93
Technical Analysis
SMA50:
643.05
SMA100:
605.82
SMA200:
598.88
52-Wk Change:
-4.17%
Stock Predictions
-
Is Regeneron Pharmaceuticals, Inc. stock public?Yes, Regeneron Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Regeneron Pharmaceuticals, Inc. stock quote today?The Regeneron Pharmaceuticals, Inc. stock price is 722.80 USD today.
-
How to buy Regeneron Pharmaceuticals, Inc. stock online?You can buy Regeneron Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 697.19 | 693.50 | 699.27 | 685.95 |
| Nov-17 | 693.34 | 704.31 | 711.88 | 692.29 |
| Nov-18 | 702.51 | 725.34 | 727.97 | 699.22 |
| Nov-19 | 727.81 | 702.75 | 727.81 | 702.63 |
| Nov-20 | 725.00 | 737.00 | 753.51 | 720.02 |
| Nov-21 | 736.01 | 755.90 | 764.09 | 735.74 |
| Nov-24 | 759.05 | 761.45 | 773.13 | 756.64 |
| Nov-25 | 764.88 | 787.32 | 790.57 | 760.01 |
| Nov-26 | 785.72 | 784.61 | 790.98 | 777.00 |
| Nov-28 | 784.70 | 780.19 | 788.98 | 779.50 |
| Dec-1 | 775.60 | 750.11 | 779.92 | 748.15 |
| Dec-2 | 742.12 | 742.00 | 747.00 | 731.00 |
| Dec-3 | 730.36 | 723.67 | 744.23 | 720.07 |
| Dec-4 | 732.45 | 722.80 | 735.00 | 721.22 |
Regeneron Pharmaceuticals, Inc. Earnings
Regeneron Pharmaceuticals, Inc. Earnings Report: Per Share Regeneron Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals, Inc. Forecast Revenue Growth
Regeneron Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $3.77 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.69 per share, and an increase next year of $0.77 per share.
* Regeneron Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.